Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Locally Advanced Solid Tumor|Metastatic Solid Tumor|Pancreatic Cancer|Lung Cancer|Head and Neck Cancer|Breast Cancer|Kidney Cancer|Colorectal Cancer|Bladder Cancer|Ovarian Cancer|Sarcoma|Gallbladder Cancer|Bile Duct Cancer|Esophageal Cancer|Uterine Cancer|Cholangiocarcinoma|Prostate Cancer
Interventions: DRUG: Seribantumab
Sponsor: Elevation Oncology